ICER Weekly View 10-06-17 image

ICER, October 6, 2017
Mitchell Stein, featuring work by Rachel E. Sachs (Academic Fellow Alumna)


Read the full review

From the review:

Medicaid’s “best price rule” has long been held up as an obstacle to value pricing – health policy/legal experts take a look and conclude that “the best-price rule is not as serious a problem as it is sometimes made out to be but that it is also not simply a convenient excuse for refusing to try something new. “

Read more here!

fda health care finance health law policy pharmaceuticals rachel sachs